🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Educational Program for the Multidisciplinary Support of Patients With Endometriosis

RecruitingNAAges 18 Years - anyFemaleCentre Hospitalier Emile Roux
NCT07134023 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: Endometriosis is a chronic gynecological condition characterized by the ectopic presence of endometrial tissue outside the uterine cavity. It affects approximately 2 to 10% of women of reproductive age and up to 50% of women with chronic pelvic pain. In France, between 1.5 and 2.5 million women are estimated to be affected. Endometriosis significantly impairs quality of life, with consequences on cognitive, behavioral, sexual, and emotional well-being, and has substantial socio-economic impact. Rationale: Current medical and surgical treatments primarily aim to reduce pain and preserve fertility but show limited effectiveness and are often discontinued due to adverse effects. Many women resort to self-management strategies, which may pose risks if not properly supervised. A multidisciplinary and integrative approach is essential to address the complex and multifactorial sy

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Signed informed consent, * Age ≥ 18 years, * Patient diagnosed with endometriosis confirmed by pelvic ultrasound and/or MRI, * Patient experiencing chronic pelvic-perineal pain (± dysmenorrhea, dyspareunia, etc.) for at least 3 months, * Ability to read and understand French, * Affiliation with a social security system or equivalent. Exclusion Criteria: * Patient having already participated in an educational program or received multidisciplinary follow-up (involving at least 3 different healthcare professionals simultaneously within the same facility) in the past 12 months, * Patient in an emergency situation, or under legal protection measures (guardianship, curatorship, or judicial protection) and unable to give consent, * For patients at the experimental center only: inability to comply with study follow-up due to geographical, social, or psychological reasons.
💊

What it tests

  • Supportive Care
📍

Where

2 sites
Clinique Axium
Aix-en-Provence, France
Centre Hospitalier Emile Roux
Le Puy-en-Velay, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy